European Companies Search Engine

No longer Managing Director: Volker Knöll · Capital: €250,000 · Share­holder agreement · Name: GEMoaB GmbH Hrb19 Oct 2020 German Trade Register Announcements, Germany

Overview

Text

HRB 30429: GEMoaB Monoclonals GmbH,
Dresden, Tatzberg 47, 01307 Dresden
. The Shareholders' Meeting of 28 September 2020 decided to increase the share capital by EUR 225,000.00 to EUR 250,000.00 and to amend Sections 1 (Company) and 4 (share capital) and to delete Section 5 (common contributions) of the partnership agreement. New company: GEMoaB GmbH. New share capital: EUR 250,000.00. Residence changed and retired: Managing Director: Knöll, Volker, Darmstadt, *??.??.????.

This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: AvenCell Europe GmbH, Dresden, Germany.

Creative Commons License The visualizations for "GEMoaB GmbH - No longer Managing Director: Volker Knöll · Capital: €250,000 · Share­holder agreement · Name: GEMoaB GmbH" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.